Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,362,443
New position
Shares Held
81,017
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#258
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CI INVESTMENTS INC. holds $846,711,661 across 10 Drug Manufacturers - General names. AZN ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
387,911 | $465,272,128 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,244,906 | $159,970,421 | |
| 3 | JNJ |
Johnson & Johnson
|
297,107 | $75,456,264 | |
| 4 | ABBV |
AbbVie Inc.
|
183,389 | $46,148,007 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
323,880 | $40,918,999 | |
| 6 | AMGN |
Amgen Inc
|
51,678 | $18,713,637 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
81,017 | $15,362,443 | |
| 8 | PFE |
Pfizer Inc
|
561,203 | $13,513,768 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,362,443 | 81,017 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||